SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997; 145: 40815.
  • 2
    Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000; 9: 1705.
  • 3
    Bruce IN, Gladman DD, Urowitz MB. Systemic lupus erythematosus: premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 25778.
  • 4
    Aranow C, Ginzler EM. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000; 9: 1669.
  • 5
    Manzi S, Kuller LH, Edmundowicz D, Sutton-Tyrrell K. Vascular imaging: changing the face of cardiovascular research. Lupus 2000; 9: 17682.
  • 6
    Wierzbicki AS. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus. Lupus 2000; 9: 194201.
  • 7
    Hallegua DS, Wallace DJ. How accelerated atherosclerosis in systemic lupus erythematosus has changed our management of the disorder. Lupus 2000; 9: 22831.
  • 8
    Gazarian M, Feldman BM, Benson LN, Gilday DL, Laxer RM, Silverman ED. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 1998; 132: 10916.
  • 9
    Hosenpud JD, Montanaro A, Hart MV, Haines JE, Specht HD, Bennett RM, et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984; 77: 28692.
  • 10
    Bruce IN, Burns RJ, Gladman DD, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol 2000; 27: 23727.
  • 11
    Schillaci O, Laganà B, Danieli R, Gentile R, Tubani L, Baratta L, et al. Technetium-99m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur J Nucl Med 1999; 26: 7137.
  • 12
    Sun SS, Shiau YC, Tsai SC, Lin CC, Kao A, Lee CC. The role of technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints. Rheumatology (Oxford) 2001; 40: 110611.
  • 13
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 14
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 15
    Departamento de Ergometria e Reabilitação Cardiovascular da Sociedade Brasileira de Cardiologia. Consenso Nacional de Ergometria. Arq Bras Cardiol 1995; 65: 189211.
  • 16
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 63040.
  • 17
    Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 3639.
  • 18
    Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 80913.
  • 19
    Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 301523.
  • 20
    National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1333445.
  • 21
    Sociedade Brasileira de Cardiologia. Segundo Consenso Brasileiro sobre dislipidemias — avaliação, detecção e tratamento. Arq Bras Cardiol 1996; 67: 10928.
  • 22
    Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434503.
  • 23
    The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999; 22 Suppl 1: S519.
  • 24
    Botvinick EH, Dae MW. Dipyridamole perfusion scintigraphy. Semin Nucl Med 1991; 21: 24265.
  • 25
    Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, et al. Guidelines for clinical use of cardiac radionuclide imaging: report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995; 25: 52147.
  • 26
    Siegel S. Estatística não-paramétrica. Sao Paulo: McGraw-Hill; 1975. p. 350.
  • 27
    Kuller LH, Shemanski L, Psaty BM, Borhani NO, Gardin J, Haan MN, et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 1995; 92: 7206.
  • 28
    Von Feldt JM. Coronary electron beam computed tomography in 13 SLE patients with 2 or more cardiovascular risk factors [abstract]. Arthritis Rheum 1998; 41 Suppl 9: S139.
  • 29
    Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol 1997; 146: 48394.
  • 30
    Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 5160.
  • 31
    Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 188793.
  • 32
    Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994; 73: 64752.
  • 33
    Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events. Am Heart J 1996; 131: 9239.
  • 34
    Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995; 26: 12028.
  • 35
    Follansbee WP. Alternatives to leg exercise in the evaluation of patients with coronary artery disease: functional and pharmacologic stress modalities. In: GersonMC, editor. Cardiac nuclear medicine. 3rd ed. New York: McGraw-Hill; 1996. p. 193235.
  • 36
    Martins LRF. Interpretação das imagens de perfusão do miocárdio. Rev Soc Cardiol Estado Sao Paulo 1995; 5: 26270.
  • 37
    Meneghelo RS. Teste ergométrico, cintilografia e cinecoronariografia: correlação e discrepâncias. Rev Soc Cardiol Estado Sao Paulo 1995; 5: 2859.
  • 38
    Melin JA, Wijns W, Vanbutsele RJ, Robert A, De Coster P, Brasseur LA, et al. Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. Circulation 1985; 71: 53542.
  • 39
    Manoucheri M, Karunaratne HB. The role of imaging techniques in stress testing. Prim Care 1994; 21: 53555.
  • 40
    Zeiher AM, Krause T, Schächinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilatation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995; 91: 234552.
  • 41
    Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96: 33905.
  • 42
    Motz W, Vogt M, Rabenau O, Scheler S, Lückhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 9961003.
  • 43
    Quyyumi AA, Cannon RO, Panza, JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992; 86: 186471.
  • 44
    Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 94854.
  • 45
    Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391401.
  • 46
    Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 65262.
  • 47
    Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1993; 91: 2937.
  • 48
    Lima DSN, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2927.
  • 49
    Sato EI, Sella EMC, Lima DDS. Myocardial perfusion scintigraphy and endothelial function in SLE patients [abstract]. Arthritis Rheum 2002; 46 Suppl 9: S53.
  • 50
    Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 115766.
  • 51
    Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 5662.
  • 52
    Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995; 92: 233342.